Annual CFI
-$4.98 M
+$8.93 M+64.19%
31 December 2023
Summary:
ADMA Biologics annual cash flow from investing activities is currently -$4.98 million, with the most recent change of +$8.93 million (+64.19%) on 31 December 2023. During the last 3 years, it has risen by +$8.53 million (+63.13%). ADMA annual CFI is now -132.74% below its all-time high of $15.21 million, reached on 31 December 2017.ADMA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$1.10 M
+$1.27 M+53.57%
30 September 2024
Summary:
ADMA Biologics quarterly cash flow from investing activities is currently -$1.10 million, with the most recent change of +$1.27 million (+53.57%) on 30 September 2024. Over the past year, it has increased by +$309.00 thousand (+21.96%). ADMA quarterly CFI is now -108.68% below its all-time high of $12.65 million, reached on 30 June 2017.ADMA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$7.23 M
-$341.00 K-4.95%
30 September 2024
Summary:
ADMA Biologics TTM cash flow from investing activities is currently -$7.23 million, with the most recent change of -$341.00 thousand (-4.95%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-45.19%). ADMA TTM CFI is now -130.57% below its all-time high of $23.66 million, reached on 30 June 2017.ADMA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +22.0% | -45.2% |
| 3 y3 years | +63.1% | +70.1% | +46.5% |
| 5 y5 years | -30.7% | +31.1% | -89.7% |
ADMA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.2% | -45.0% | +72.1% | -45.2% | +48.0% |
| 5 y | 5 years | -30.7% | +64.2% | -45.0% | +75.5% | -89.7% | +48.0% |
| alltime | all time | -132.7% | +64.2% | -108.7% | +87.3% | -130.6% | +48.0% |
ADMA Biologics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.10 M(-53.6%) | -$7.23 M(+4.9%) |
| June 2024 | - | -$2.37 M(+0.1%) | -$6.89 M(+27.7%) |
| Mar 2024 | - | -$2.36 M(+67.9%) | -$5.40 M(+8.4%) |
| Dec 2023 | -$4.98 M(-64.2%) | -$1.41 M(+85.9%) | -$4.98 M(-32.0%) |
| Sept 2023 | - | -$757.00 K(-13.2%) | -$7.32 M(-26.4%) |
| June 2023 | - | -$872.00 K(-55.2%) | -$9.95 M(-23.6%) |
| Mar 2023 | - | -$1.95 M(-48.1%) | -$13.01 M(-6.4%) |
| Dec 2022 | -$13.91 M(+3.0%) | -$3.75 M(+10.9%) | -$13.91 M(+0.5%) |
| Sept 2022 | - | -$3.38 M(-14.2%) | -$13.84 M(+4.5%) |
| June 2022 | - | -$3.94 M(+38.6%) | -$13.25 M(-3.9%) |
| Mar 2022 | - | -$2.84 M(-22.7%) | -$13.78 M(+2.0%) |
| Dec 2021 | -$13.51 M(+6.2%) | -$3.68 M(+31.8%) | -$13.51 M(+0.6%) |
| Sept 2021 | - | -$2.79 M(-37.7%) | -$13.43 M(-0.7%) |
| June 2021 | - | -$4.48 M(+74.1%) | -$13.53 M(+2.3%) |
| Mar 2021 | - | -$2.57 M(-28.5%) | -$13.22 M(+3.9%) |
| Dec 2020 | -$12.72 M(+233.8%) | -$3.60 M(+24.7%) | -$12.72 M(+18.7%) |
| Sept 2020 | - | -$2.89 M(-30.8%) | -$10.72 M(+9.3%) |
| June 2020 | - | -$4.17 M(+101.1%) | -$9.81 M(+69.8%) |
| Mar 2020 | - | -$2.07 M(+30.0%) | -$5.77 M(+51.5%) |
| Dec 2019 | -$3.81 M(+81.9%) | -$1.59 M(-19.1%) | -$3.81 M(+25.5%) |
| Sept 2019 | - | -$1.97 M(+1358.5%) | -$3.04 M(+134.5%) |
| June 2019 | - | -$135.20 K(+22.4%) | -$1.29 M(-21.8%) |
| Mar 2019 | - | -$110.50 K(-86.5%) | -$1.66 M(-20.9%) |
| Dec 2018 | -$2.10 M(-113.8%) | -$819.00 K(+255.8%) | -$2.10 M(-36.2%) |
| Sept 2018 | - | -$230.20 K(-53.7%) | -$3.29 M(-9.4%) |
| June 2018 | - | -$497.10 K(-9.5%) | -$3.63 M(-138.1%) |
| Mar 2018 | - | -$549.20 K(-72.7%) | $9.52 M(-37.4%) |
| Dec 2017 | $15.21 M | -$2.01 M(+252.7%) | $15.21 M(-33.4%) |
| Sept 2017 | - | -$569.90 K(-104.5%) | $22.85 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $12.65 M(+146.1%) | $23.66 M(+889.8%) |
| Mar 2017 | - | $5.14 M(-8.6%) | $2.39 M(+164.2%) |
| Dec 2016 | $904.60 K(-151.9%) | $5.63 M(+2255.2%) | $904.60 K(+33.3%) |
| Sept 2016 | - | $238.90 K(-102.8%) | $678.80 K(-85.2%) |
| June 2016 | - | -$8.62 M(-335.7%) | $4.60 M(-47.7%) |
| Mar 2016 | - | $3.66 M(-32.3%) | $8.79 M(-604.6%) |
| Dec 2015 | -$1.74 M(-56.9%) | $5.40 M(+29.9%) | -$1.74 M(-71.1%) |
| Sept 2015 | - | $4.16 M(-193.9%) | -$6.03 M(-48.0%) |
| June 2015 | - | -$4.43 M(-35.6%) | -$11.59 M(+0.5%) |
| Mar 2015 | - | -$6.87 M(-718.9%) | -$11.53 M(+185.5%) |
| Dec 2014 | -$4.04 M(+29.0%) | $1.11 M(-179.2%) | -$4.04 M(-50.1%) |
| Sept 2014 | - | -$1.40 M(-67.9%) | -$8.09 M(+20.7%) |
| June 2014 | - | -$4.37 M(-804.5%) | -$6.71 M(+174.2%) |
| Mar 2014 | - | $620.20 K(-121.1%) | -$2.45 M(-21.9%) |
| Dec 2013 | -$3.13 M(+2534.0%) | -$2.94 M(>+9900.0%) | -$3.13 M(+1282.7%) |
| Sept 2013 | - | -$16.40 K(-84.9%) | -$226.50 K(-4.6%) |
| June 2013 | - | -$108.70 K(+64.4%) | -$237.50 K(+28.4%) |
| Mar 2013 | - | -$66.10 K(+87.3%) | -$185.00 K(+55.6%) |
| Dec 2012 | -$118.90 K(<-9900.0%) | -$35.30 K(+28.8%) | -$118.90 K(+42.2%) |
| Sept 2012 | - | -$27.40 K(-51.2%) | -$83.60 K(+48.8%) |
| June 2012 | - | -$56.20 K(<-9900.0%) | -$56.20 K(<-9900.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00 | $0.00 |
| June 2010 | $0.00 | - | - |
FAQ
- What is ADMA Biologics annual cash flow from investing activities?
- What is the all time high annual CFI for ADMA Biologics?
- What is ADMA Biologics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ADMA Biologics?
- What is ADMA Biologics quarterly CFI year-on-year change?
- What is ADMA Biologics TTM cash flow from investing activities?
- What is the all time high TTM CFI for ADMA Biologics?
- What is ADMA Biologics TTM CFI year-on-year change?
What is ADMA Biologics annual cash flow from investing activities?
The current annual CFI of ADMA is -$4.98 M
What is the all time high annual CFI for ADMA Biologics?
ADMA Biologics all-time high annual cash flow from investing activities is $15.21 M
What is ADMA Biologics quarterly cash flow from investing activities?
The current quarterly CFI of ADMA is -$1.10 M
What is the all time high quarterly CFI for ADMA Biologics?
ADMA Biologics all-time high quarterly cash flow from investing activities is $12.65 M
What is ADMA Biologics quarterly CFI year-on-year change?
Over the past year, ADMA quarterly cash flow from investing activities has changed by +$309.00 K (+21.96%)
What is ADMA Biologics TTM cash flow from investing activities?
The current TTM CFI of ADMA is -$7.23 M
What is the all time high TTM CFI for ADMA Biologics?
ADMA Biologics all-time high TTM cash flow from investing activities is $23.66 M
What is ADMA Biologics TTM CFI year-on-year change?
Over the past year, ADMA TTM cash flow from investing activities has changed by -$2.25 M (-45.19%)